Research ArticleArticle
Heme Modification Contributes to the Mechanism-Based Inactivation of Human Cytochrome P450 2J2 by Two Terminal Acetylenic Compounds
Hsia-lien Lin, Haoming Zhang, Vyvyca J. Walker, Jaime D'Agostino and Paul F. Hollenberg
Drug Metabolism and Disposition July 11, 2017, dmd.117.075846; DOI: https://doi.org/10.1124/dmd.117.075846
Hsia-lien Lin
1 The University of Michigan;
Haoming Zhang
1 The University of Michigan;
Vyvyca J. Walker
2 University of Michigan;
Jaime D'Agostino
1 The University of Michigan;
Paul F. Hollenberg
3 University of Michigan School of Medicine
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Heme Modification Contributes to the Mechanism-Based Inactivation of Human Cytochrome P450 2J2 by Two Terminal Acetylenic Compounds
Hsia-lien Lin, Haoming Zhang, Vyvyca J. Walker, Jaime D'Agostino and Paul F. Hollenberg
Drug Metabolism and Disposition July 11, 2017, dmd.117.075846; DOI: https://doi.org/10.1124/dmd.117.075846
Research ArticleArticle
Heme Modification Contributes to the Mechanism-Based Inactivation of Human Cytochrome P450 2J2 by Two Terminal Acetylenic Compounds
Hsia-lien Lin, Haoming Zhang, Vyvyca J. Walker, Jaime D'Agostino and Paul F. Hollenberg
Drug Metabolism and Disposition July 11, 2017, dmd.117.075846; DOI: https://doi.org/10.1124/dmd.117.075846
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement